Low-Dose Aspirin Is the Safest Prophylaxis for Prevention of Venous Thromboembolism After Total Knee Arthroplasty Across All Patient Risk Profiles
Niedrig dosiertes Aspirin ist die sicherste Prophylaxe zur Prävention venöser Thromboembolien nach totaler Kniearthroplastik über alle Risikoprofile hinweg
Journal of Bone and Joint Surgery · 17.07.2024 · 106 (14) · 1256-1267
DOI: 10.2106/jbjs.23.01158 ↗Auf einen Blick
Eine nationale Datenbankstudie fand bei TKA-Patient:innen: Niedrig dosiertes Aspirin wurde zwischen 2012 und 2022 deutlich häufiger eingesetzt und war mit günstigeren 90-Tage-Ergebnissen verbunden.
Fragestellung
Wie wirksam ist Aspirin im Vergleich zu anderen Thromboprophylaxen nach totaler Kniearthroplastik bei Patient:innen mit unterschiedlichem VTE-Risiko?
Methode
Nationale Datenbankstudie; TKA-Patient:innen 2012 bis 2022; Einteilung nach ICM-VTE-Risikoprofilen; Vergleich von niedrig dosiertem Aspirin (81 mg) mit anderer Chemoprophylaxe; OR und 95 %-KI.
Ergebnisse
126.692 Patient:innen aus 60 Gesundheitseinrichtungen. Niedrig dosiertes Aspirin: 7,65 % auf 55,29 %; andere Chemoprophylaxe: 96,25 % auf 42,98 %. Niedrig dosiertes Aspirin war mit geringeren Odds für DVT, PE, Blutung, Infektionen und Hospitalisationen verbunden.
Schlussfolgerung der Autor:innen
Die Ergebnisse stützen die ICM-VTE-Aussage, dass niedrig dosiertes Aspirin bei Patient:innen mit unterschiedlichen Risikoprofilen eine sichere und wirksame Prophylaxe ist.
Kernaussagen
- Niedrig dosiertes Aspirin nahm zwischen 2012 und 2022 deutlich zu
- In beiden Risikogruppen wurden günstigere 90-Tage-Ergebnisse berichtet
- Low-dose-Aspirin-only war bei Niedrigrisiko häufiger als bei Hochrisiko
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift Journal of Bone and Joint Surgery, online erschienen am 16.05.2024. Verfasst von Monish S Lavu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics, Case Western Reserve University School of Medicine, Cleveland, Ohio. Hauptthemen laut MEDLINE: Arthroplasty, Replacement, Knee, Aspirin, Venous Thromboembolism. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS.
Themen: Thromboseprophylaxe
Abstract (Originalsprache)
Background
The International Consensus Meeting on Venous Thromboembolism (ICM-VTE) in 2022 proclaimed low-dose aspirin as the most effective agent in patients across all risk profiles undergoing joint arthroplasty. However, data on large patient populations assessing trends in chemoprophylactic choices and related outcomes following total knee arthroplasty (TKA) remain scant. The present study was designed to characterize the clinical use of various chemoprophylactic agents in patients undergoing TKA and to determine the efficacy of aspirin compared with other agents in patient groups stratified by VTE risk profiles.
Methods
This study utilized a national database to determine the proportion of patients undergoing TKA who received low-dose aspirin versus other chemoprophylaxis between 2012 and 2022. VTE risk profiles were determined on the basis of comorbidities established in the ICM-VTE. The odds ratios (ORs) and 95% confidence intervals (CIs) between various classes of thromboprophylaxis in patients with high and low risk of VTE were calculated. The odds of deep-vein thrombosis (DVT), pulmonary embolus (PE), bleeding events, infections, mortality, and hospitalizations were also assessed in the 90-day postoperative period for propensity-matched cohorts receiving low-dose (81 mg) aspirin only versus other prophylaxis, segregating patients by VTE risk profile.
Results
A total of 126,692 patients undergoing TKA across 60 health-care organizations were included. The proportion of patients receiving low-dose aspirin increased from 7.65% to 55.29% between 2012 and 2022, whereas the proportion of patients receiving other chemoprophylaxis decreased from 96.25% to 42.98%. Low-dose-aspirin-only use increased to approximately 50% in both high-risk and low-risk populations but was more likely in low-risk populations (OR, 1.17; 95% CI, 1.15 to 1.20) relative to high-risk populations. Both low-risk and high-risk patients in the low-dose-aspirin-only cohorts had decreased odds of DVT, PE, bleeding, infections, and hospitalizations compared with other prophylaxis regimens.
Conclusions
The findings of the present study on a very large population of patients undergoing TKA support the recent ICM-VTE statement by showing that low-dose aspirin is a safe and effective method of prophylaxis in patients across various risk profiles. Level of Evidence: Therapeutic Level III . See Instructions for Authors for a complete description of levels of evidence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Orthopaedics, Case Western Reserve University School of Medicine, Cleveland, Ohio.
- Department of Orthopaedic Surgery, Cleveland Clinic Foundation, Cleveland, Ohio.
- Department of Orthopaedics, Rush University Medical Center, Chicago, Illinois.
- Departments of Internal Medicine, Pediatrics, and Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, Ohio.
- Center for Clinical Informatics Research and Education, The MetroHealth System, Cleveland, Ohio.
- Rothman Orthopaedic Institute at Thomas Jefferson University, Philadelphia, Pennsylvania.
ORCID-Profile: Monish S Lavu, Joshua R Porto, Christian J Hecht, Alexander J Acuña, David C Kaelber, Javad Parvizi, Atul F Kamath
Förderung
- NCATS NIH HHS
Zitieren
APA
Lavu, M. S., Porto, J. R., Hecht, C. J., Acuña, A. J., Kaelber, D. C., Parvizi, J., & Kamath, A. F. (2024). Low-Dose Aspirin Is the Safest Prophylaxis for Prevention of Venous Thromboembolism After Total Knee Arthroplasty Across All Patient Risk Profiles. Journal of Bone and Joint Surgery, 106(14), 1256-1267. https://doi.org/10.2106/jbjs.23.01158
Vancouver
Lavu MS, Porto JR, Hecht CJ, Acuña AJ, Kaelber DC, Parvizi J, et al. Low-Dose Aspirin Is the Safest Prophylaxis for Prevention of Venous Thromboembolism After Total Knee Arthroplasty Across All Patient Risk Profiles. Journal of Bone and Joint Surgery. 2024;106(14):1256-1267. doi:10.2106/jbjs.23.01158
BibTeX
@article{Lavu2024,
author = {Lavu, Monish S and Porto, Joshua R and Hecht, Christian J and Acuña, Alexander J and Kaelber, David C and Parvizi, Javad and Kamath, Atul F},
title = {Low-Dose Aspirin Is the Safest Prophylaxis for Prevention of Venous Thromboembolism After Total Knee Arthroplasty Across All Patient Risk Profiles},
journal = {Journal of Bone and Joint Surgery},
year = {2024},
volume = {106},
number = {14},
pages = {1256--1267},
doi = {10.2106/jbjs.23.01158}
}
EUVIMED